Drug Companies Should Develop "Produce-To-Give" Programs, Study Says
This article was originally published in The Tan Sheet
Executive Summary
Drug manufacturers making donations to international charity organizations as a form of inventory management should develop "produce-to-give" programs, a Harvard School of Public Health study recommends.